China Immunotech (beijing) Biotechnology Co., Ltd.

This early-stage trial tests a new cell therapy called YTS109 for people with autoimmune hemolytic anemia (AIHA) that hasn't improved after at least three prior treatments. The therapy uses specially designed immune cells to target and destroy the faulty cells causing the disease…